214 related articles for article (PubMed ID: 27456946)
1. Blocking Interleukin-4 Receptor α Using Polyethylene Glycol Functionalized Superparamagnetic Iron Oxide Nanocarriers to Inhibit Breast Cancer Cell Proliferation.
Shaik AP; Shaik AS; Majwal AA; Faraj AA
Cancer Res Treat; 2017 Apr; 49(2):322-329. PubMed ID: 27456946
[TBL] [Abstract][Full Text] [Related]
2. Specific targeting and noninvasive magnetic resonance imaging of an asthma biomarker in the lung using polyethylene glycol functionalized magnetic nanocarriers.
Al Faraj A; Shaik AS; Afzal S; Al-Muhsen S; Halwani R
Contrast Media Mol Imaging; 2016 May; 11(3):172-83. PubMed ID: 26708935
[TBL] [Abstract][Full Text] [Related]
3. Anti-VCAM-1 and Anti-IL4Rα Aptamer-Conjugated Super Paramagnetic Iron Oxide Nanoparticles for Enhanced Breast Cancer Diagnosis and Therapy.
Chinnappan R; Al Faraj A; Abdel Rahman AM; Abu-Salah KM; Mouffouk F; Zourob M
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751068
[TBL] [Abstract][Full Text] [Related]
4. Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells.
Tarvirdipour S; Vasheghani-Farahani E; Soleimani M; Bardania H
Int J Pharm; 2016 Mar; 501(1-2):331-41. PubMed ID: 26875475
[TBL] [Abstract][Full Text] [Related]
5. Magnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarker.
Al Faraj A; Shaik AP; Shaik AS
Int J Nanomedicine; 2015; 10():157-68. PubMed ID: 25565811
[TBL] [Abstract][Full Text] [Related]
6. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of superparamagnetic iron oxide nanoparticles for magnetically guided drug delivery.
Kumar P; Agnihotri S; Roy I
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):43-46. PubMed ID: 30880956
[TBL] [Abstract][Full Text] [Related]
8. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
[TBL] [Abstract][Full Text] [Related]
9. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
[TBL] [Abstract][Full Text] [Related]
10. Aptamer-assisted superparamagnetic iron oxide nanoparticles as multifunctional drug delivery platform for chemo-photodynamic combination therapy.
Sun X; Liu B; Chen X; Lin H; Peng Y; Li Y; Zheng H; Xu Y; Ou X; Yan S; Wu Z; Deng S; Zhang L; Zhao P
J Mater Sci Mater Med; 2019 Jun; 30(7):76. PubMed ID: 31218573
[TBL] [Abstract][Full Text] [Related]
11. PPARs are mediators of anti-cancer properties of superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with conjugated linoleic acid.
Ricci M; Miola M; Multari C; Borroni E; Canuto RA; Congiusta N; Vernè E; Follenzi A; Muzio G
Chem Biol Interact; 2018 Aug; 292():9-14. PubMed ID: 29986832
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and in vitro evaluation of exquisite targeting SPIONs-PEG-HER in HER2+ human breast cancer cells.
Almaki JH; Nasiri R; Idris A; Majid FA; Salouti M; Wong TS; Dabagh S; Marvibaigi M; Amini N
Nanotechnology; 2016 Mar; 27(10):105601. PubMed ID: 26861770
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells.
Vyas D; Lopez-Hisijos N; Gandhi S; El-Dakdouki M; Basson MD; Walsh MF; Huang X; Vyas AK; Chaturvedi LS
J Nanosci Nanotechnol; 2015 Sep; 15(9):6413-22. PubMed ID: 26690867
[TBL] [Abstract][Full Text] [Related]
14. IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth.
Venmar KT; Kimmel DW; Cliffel DE; Fingleton B
Biochim Biophys Acta; 2015 May; 1853(5):1219-28. PubMed ID: 25746764
[TBL] [Abstract][Full Text] [Related]
15. Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.
Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S; Shahzad S
Appl Biochem Biotechnol; 2014 May; 173(1):36-54. PubMed ID: 24615524
[TBL] [Abstract][Full Text] [Related]
16. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth.
Guruprasath P; Kim J; Gunassekaran GR; Chi L; Kim S; Park RW; Kim SH; Baek MC; Bae SM; Kim SY; Kim DK; Park IK; Kim WJ; Lee B
Biomaterials; 2017 Oct; 142():101-111. PubMed ID: 28732245
[TBL] [Abstract][Full Text] [Related]
18. Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery.
Sabnis S; Sabnis NA; Raut S; Lacko AG
Int J Nanomedicine; 2017; 12():1453-1464. PubMed ID: 28260891
[TBL] [Abstract][Full Text] [Related]
19. Investigation of adhesive interactions in the specific targeting of Triptorelin-conjugated PEG-coated magnetite nanoparticles to breast cancer cells.
Hu J; Youssefian S; Obayemi J; Malatesta K; Rahbar N; Soboyejo W
Acta Biomater; 2018 Apr; 71():363-378. PubMed ID: 29458110
[TBL] [Abstract][Full Text] [Related]
20. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
Shroff K; Kokkoli E
Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
